Form 8-K - Current report:
SEC Accession No. 0001566044-21-000015
Filing Date
2021-03-30
Accepted
2021-03-30 16:53:25
Documents
53
Period of Report
2021-03-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnlo-20210330.htm   iXBRL 8-K 34959
2 EX-99.1 vyneinvestorpresentation.htm EX-99.1 46259
8 GRAPHIC vyneinvestorpresentation001.jpg GRAPHIC 105256
9 GRAPHIC vyneinvestorpresentation002.jpg GRAPHIC 167464
10 GRAPHIC vyneinvestorpresentation003.jpg GRAPHIC 97689
11 GRAPHIC vyneinvestorpresentation004.jpg GRAPHIC 82807
12 GRAPHIC vyneinvestorpresentation005.jpg GRAPHIC 96881
13 GRAPHIC vyneinvestorpresentation006.jpg GRAPHIC 113723
14 GRAPHIC vyneinvestorpresentation007.jpg GRAPHIC 94068
15 GRAPHIC vyneinvestorpresentation008.jpg GRAPHIC 65071
16 GRAPHIC vyneinvestorpresentation009.jpg GRAPHIC 78109
17 GRAPHIC vyneinvestorpresentation010.jpg GRAPHIC 112499
18 GRAPHIC vyneinvestorpresentation011.jpg GRAPHIC 79092
19 GRAPHIC vyneinvestorpresentation012.jpg GRAPHIC 86797
20 GRAPHIC vyneinvestorpresentation013.jpg GRAPHIC 92150
21 GRAPHIC vyneinvestorpresentation014.jpg GRAPHIC 78803
22 GRAPHIC vyneinvestorpresentation015.jpg GRAPHIC 100885
23 GRAPHIC vyneinvestorpresentation016.jpg GRAPHIC 76710
24 GRAPHIC vyneinvestorpresentation017.jpg GRAPHIC 66607
25 GRAPHIC vyneinvestorpresentation018.jpg GRAPHIC 65981
26 GRAPHIC vyneinvestorpresentation019.jpg GRAPHIC 65785
27 GRAPHIC vyneinvestorpresentation020.jpg GRAPHIC 63539
28 GRAPHIC vyneinvestorpresentation021.jpg GRAPHIC 72244
29 GRAPHIC vyneinvestorpresentation022.jpg GRAPHIC 95976
30 GRAPHIC vyneinvestorpresentation023.jpg GRAPHIC 109347
31 GRAPHIC vyneinvestorpresentation024.jpg GRAPHIC 66146
32 GRAPHIC vyneinvestorpresentation025.jpg GRAPHIC 67281
33 GRAPHIC vyneinvestorpresentation026.jpg GRAPHIC 104980
34 GRAPHIC vyneinvestorpresentation027.jpg GRAPHIC 93883
35 GRAPHIC vyneinvestorpresentation028.jpg GRAPHIC 109402
36 GRAPHIC vyneinvestorpresentation029.jpg GRAPHIC 94451
37 GRAPHIC vyneinvestorpresentation030.jpg GRAPHIC 129155
38 GRAPHIC vyneinvestorpresentation031.jpg GRAPHIC 112335
39 GRAPHIC vyneinvestorpresentation032.jpg GRAPHIC 93920
40 GRAPHIC vyneinvestorpresentation033.jpg GRAPHIC 87719
41 GRAPHIC vyneinvestorpresentation034.jpg GRAPHIC 111824
42 GRAPHIC vyneinvestorpresentation035.jpg GRAPHIC 72468
43 GRAPHIC vyneinvestorpresentation036.jpg GRAPHIC 150913
44 GRAPHIC vyneinvestorpresentation037.jpg GRAPHIC 142162
45 GRAPHIC vyneinvestorpresentation038.jpg GRAPHIC 40250
  Complete submission text file 0001566044-21-000015.txt   5134025

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlo-20210330.xsd EX-101.SCH 2547
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnlo-20210330_cal.xml EX-101.CAL 821
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnlo-20210330_def.xml EX-101.DEF 1785
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlo-20210330_lab.xml EX-101.LAB 25280
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlo-20210330_pre.xml EX-101.PRE 13298
46 EXTRACTED XBRL INSTANCE DOCUMENT mnlo-20210330_htm.xml XML 11687
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 21787024
SIC: 2834 Pharmaceutical Preparations